Cargando…
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
The molecular manifestations of host cells responding to SARS-CoV-2 and its evolving variants of infection are vastly different across the studied models and conditions, imposing challenges for host-based antiviral drug discovery. Based on the postulation that antiviral drugs tend to reverse the glo...
Autores principales: | Xing, Jing, Shankar, Rama, Ko, Meehyun, Zhang, Keke, Zhang, Sulin, Drelich, Aleksandra, Paithankar, Shreya, Chekalin, Eugene, Chua, Mei-Sze, Rajasekaran, Surender, Kent Tseng, Chien-Te, Zheng, Mingyue, Kim, Seungtaek, Chen, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439871/ https://www.ncbi.nlm.nih.gov/pubmed/36093376 http://dx.doi.org/10.1016/j.isci.2022.105068 |
Ejemplares similares
-
Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19
por: Xing, Jing, et al.
Publicado: (2020) -
Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals
por: Xing, Jing, et al.
Publicado: (2021) -
Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals
por: Xing, Jing, et al.
Publicado: (2021) -
BGLM: big data-guided LOINC mapping with multi-language support
por: Liu, Ke, et al.
Publicado: (2022) -
Detection of viral infection in cell lines using ViralCellDetector
por: Shankar, Rama, et al.
Publicado: (2023)